TR-002

· University of California, Davis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TR-002, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]

See pricing